Virkamäki A - Search Results

1

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Virkamäki A, Ueki K, Kahn CR. Virkamäki A, et al. J Clin Invest. 1999 Apr;103(7):931-43. doi: 10.1172/JCI6609. J Clin Invest. 1999. PMID: 10194465 Free PMC article. Review. No abstract available.

2

Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle.

Patti ME, Virkamäki A, Landaker EJ, Kahn CR, Yki-Järvinen H. Patti ME, et al. Among authors: virkamaki a. Diabetes. 1999 Aug;48(8):1562-71. doi: 10.2337/diabetes.48.8.1562. Diabetes. 1999. PMID: 10426374

3

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR, Kahn BB. Zisman A, et al. Among authors: virkamaki a. Nat Med. 2000 Aug;6(8):924-8. doi: 10.1038/78693. Nat Med. 2000. PMID: 10932232

4

A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes.

Mauvais-Jarvis F, Virkamaki A, Michael MD, Winnay JN, Zisman A, Kulkarni RN, Kahn CR. Mauvais-Jarvis F, et al. Among authors: virkamaki a. Diabetes. 2000 Dec;49(12):2126-34. doi: 10.2337/diabetes.49.12.2126. Diabetes. 2000. PMID: 11118016

5

Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart.

Virkamäki A, Yki-Järvinen H. Virkamäki A, et al. Diabetes. 1999 May;48(5):1101-7. doi: 10.2337/diabetes.48.5.1101. Diabetes. 1999. PMID: 10331416

6

Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle.

Virkamäki A, Korsheninnikova E, Seppälä-Lindroos A, Vehkavaara S, Goto T, Halavaara J, Häkkinen AM, Yki-Järvinen H. Virkamäki A, et al. Diabetes. 2001 Oct;50(10):2337-43. doi: 10.2337/diabetes.50.10.2337. Diabetes. 2001. PMID: 11574417

7

Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM.

Yki-Järvinen H, Daniels MC, Virkamäki A, Mäkimattila S, DeFronzo RA, McClain D. Yki-Järvinen H, et al. Among authors: virkamaki a. Diabetes. 1996 Mar;45(3):302-7. doi: 10.2337/diab.45.3.302. Diabetes. 1996. PMID: 8593934

8

Incorporation of [3-3H]glucose and 2-[1-14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake.

Virkamäki A, Rissanen E, Hämäläinen S, Utriainen T, Yki-Järvinen H. Virkamäki A, et al. Diabetes. 1997 Jul;46(7):1106-10. doi: 10.2337/diab.46.7.1106. Diabetes. 1997. PMID: 9200643

9

Mechanisms of insulin resistance during acute endotoxemia.

Virkamäki A, Yki-Järvinen H. Virkamäki A, et al. Endocrinology. 1994 May;134(5):2072-8. doi: 10.1210/endo.134.5.8156907. Endocrinology. 1994. PMID: 8156907

10

Insulin resistance in type I diabetes mellitus: a major role for reduced glucose extraction.

Mäkimattila S, Virkamäki A, Malmström R, Utriainen T, Yki-Jarvinen H. Mäkimattila S, et al. Among authors: virkamaki a. J Clin Endocrinol Metab. 1996 Feb;81(2):707-12. doi: 10.1210/jcem.81.2.8636292. J Clin Endocrinol Metab. 1996. PMID: 8636292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters